Provista Diagnostics is a leading medical diagnostics company based in Alpharetta, GA, that is dedicated to simplifying early cancer detection. With a commitment to excellence, Provista creates, produces, and markets innovative solutions for unmet clinical needs. Their products and services help diagnose diseases and provide valuable information for better clinical decisions, ultimately enhancing health and improving quality of life.

Provista operates a CLIA/CAP certified lab in Alpharetta, GA, offering a range of advanced diagnostic services. Their FDA EUA approved qPCR + Neutralizing Ab Tests provide accurate results with a quick turnaround time of 6-24 hours. The lab has an impressive daily throughput of over 7,000 PCR tests and operates in a spacious 10,000 square foot BSL2 facility.

Specializing in breast cancer diagnostics, Provista combines cutting-edge technology with high-complexity molecular CLIA lab capabilities. Their comprehensive testing menu includes the Videssa® Breast Cancer Blood Test, LymPro Lymphocyte Proliferation Test, Tollotest Coronovirus 3CL Protease Test, and the AI Cancer Platform TBIA. Provista Diagnostics prides itself on its partnerships and collaborative efforts to continually stay at the forefront of breakthroughs in early cancer detection.

Stay informed of their latest advancements by following them on LinkedIn, Twitter, and Facebook. (Contact information and copyright details omitted for brevity)